By
Drug Target Review2024-10-15T12:00:24
Announced at the International Investment Summit, Lilly plan to support early-stage life sciences businesses to develop therapeutics for significant health challenges.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-08T12:00:00Z
2026-07-07T12:00:00Z
2026-05-22T07:38:00
Contributor Dr Helen Bright, By Drug Target Review
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, By Drug Target Review
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-07-04T10:05:58
Sponsored by Revvity
2026-05-05T13:24:00
Sponsored by HUB Organoids
Site powered by Webvision Cloud